drugset / Trial / NCT07743723
A Study of IOV-5001 in Adults With Advanced Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
A Phase 1/2, multicenter, multi-cohort, open-label study of an autologous tumor-infiltrating lymphocytes (TIL) regimen with IOV-5001 in participants with previously treated advanced solid tumors
Timeline
- Start
- 2026-09
- Primary completion
- 2034-03
- Completion
- 2044-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IOV-5001 | Cell therapy | — | — |